Get regular mammograms starting at age 50.
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Re: A Prospective Study of Incident Squamous Cell Carcinoma of the Skin in the Nurses' Health Study
In this excellent paper, Grodstein et al. (7) stated that, to their knowledge, only two studies have been conducted in humans evaluating cigarette smoking as a risk factor for squamous cell carcinoma (SCC). They refer to prior studies by Aubry and MacGibbon (2) and Karagas et al. (J) . In 1990, we published a study on risk factors for SCC of the skin in Saskatchewan, Canada, and included an extensive questionnaire on smoking as a possible risk factor (4) . No association was noted in our study between smoking and SCC. In our study, the most important risk factors for SCC of the skin in women were agricultural occupation (relative risk [RR] = 1.83) and skin types of 1 or 2 (RR = 1.48) (5). The article by Wang et al. (7) on diet and proliferation of transplanted LNCaP tumors in nude mice suggests that a reduced intake of dietary fat would be of therapeutic benefit to patients with metastatic prostate cancer. LNCaP cells were originally isolated from the lymph node of a patient with metastatic prostate cancer.
The authors present an excellent design and implementation of an exercise involving transplanted tumor cells. However, the basic issue here is the development and use of appropriate model systems as counterparts to diseases in humans. There are artifacts in experimental oncology that are called model systems. The tumor system reported here in nude mice is exemplary of them. It is not a model of prostate cancer in men.
Model systems involving transplanted tumors are of historical importance; such studies, however, must be confirmed by work with autochthonous tumor systems. Unfortunately, we rarely see such confirmation. Autochthonous systems are now available for cancers that develop in the breast, intestine, prostate, and bladder. Model systems of neoplastic diseases should encompass the evolutionary stages of disease, not the end stage. As an example of autochthonous prostate cancer, Lobund-Wistar (L-W) strain rats develop metastasizing adenocarcinomas in the prostate and seminal vesicles, spontaneously and by induction (2) . The tumors relate to many aspects of prostate cancer in humans, except for metastasis to bone. With this system, prostate cancer is being investigated for genetic susceptibility and for the role(s) of environmental factors (nutrition), hormone status, and the effects of aging and immune status on tumor development. The tumorigenic process can be examined from initiation to promotion to progression and metastasis, as applied to prevention and therapy for the disease. Thus far, the L-W system has demonstrated that the incidence of metastasizing spontaneous tumors can be reduced from 25.7% to 6.3% by a 30% reduction of daily caloric intake, with the average latent periods of the tumors extended from 26.6 to 36.7 months, respectively (3). However, once malignancy developed, dietary restriction was of no therapeutic benefit. The incidence of large autochthonous testosterone-promoted tumors was changed from 17.5% to 5% by reduction of dietary fat from 20% to 5% (4), but such benefit was not demonstrable after the development of malignancy.
Autochthonous tumorigenesis is the only acceptable model as a counterpart to neoplasms in humans. The era of transplanted tumors as models of human disease has progressed to studies using animals with autochthonous tumors. Transplantation experiments are preferred because they yield a high volume of results in a relatively short time span; however, the assessment of those results does not equate with better understanding of the disease. It is time to move on.
My comments are directed at the system, not specifically at the article by Wangetal. (7).
MORRIS POLLARD, M.D.
Lobund Laboratory University of Notre Dame
Notre Dame, IN 46556 Response In his letter to the editor, Pollard states that only autochthonous models have value as tumor models and that transplantable model systems are only of historical significance. All models are imperfect representations of tumors in humans.
Strong epidemiologic evidence suggests that the worldwide incidence of microfocal cancers in the prostate is nearly the same, yet in countries like the United States, manyfold more prostate cancers progress to clinically relevant disease than in Asian Pacific Rim countries. Thus, it is important to identify factors that support the growth of "established" tumors and to determine whether removal of such "progression" factors might be beneficial in patients with clinically relevant prostate cancer. Epidemiologic data strongly suggest that high levels of fat in the American diet support tumor progression. Would reducing dietary fat slow the progression of prostate cancer in patients and reduce the recurrence rate expected following therapy for localized disease? Results using the transplantable human LNCaP model suggest that a reduction in dietary fat could be helpful in reducing the rate of tumor growth (7).
We have also found that a low-fat diet reduces the growth of orthotopically transplanted LNCaP cells, which supports the viability of the LNCaP model (Corr JC, Fair WR, Heston WD: unpublished results). Most clinically relevant prostate cancers are being detected and followed by serum prostate-specific antigen (PSA) measurements. LNCaP is one of the few models that produces PSA. We wanted to know whether modification of dietary fat would interfere with the use of PSA as an intermediary marker of tumor progression and found that it did not (7). PSA is not produced by the Lobund-Wistar model described by Pollard. Indeed, rodent prostates often differ from human prostates in the type of specific proteins that are produced.
The identity and pattern of the genetic abnormalities responsible for the development of clinically relevant prostate cancer in the United States have not been established. However, it is very unusual to observe the development of cancer in the seminal vesicles of men. In the autochthonous tumor in LobundWistar rats, the development of tumors of the seminal vesicles are very common. Thus, one may question whether the tumor that develops in the LobundWistar rat is similar to the human disease.
In an editorial, Jasny (2) states that "It has been [her] experience that investigators who deal with model systems tend to be chauvinistic about their beasts." Tumor model systems continue to evolve to better represent the real thing; nevertheless, each model presently available has limitations, including the transplantable LNCaP and autochthonous Lobund-Wistar models. At the Memorial Sloan-Kettering Cancer Center, we hope that we are not chauvinists and will use all appropriate models to defeat the real beast.
